Pharmacokinetics of dolasetron following single- and multiple-dose intravenous administration to normal male subjects
- 1 April 1995
- journal article
- clinical trial
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 16 (3) , 177-189
- https://doi.org/10.1002/bdd.2510160303
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Determination of dolasetron and its reduced metabolite in human plasma by GC—MS and LCJournal of Pharmaceutical and Biomedical Analysis, 1993
- Human dolasetron pharmacokinetics: II Absorption and disposition following single‐dose oral administration to normal male subjectsBiopharmaceutics & Drug Disposition, 1993
- Human dolasetron pharmacokinetics: I. Disposition following single‐dose intravenous administration to normal male subjectsBiopharmaceutics & Drug Disposition, 1992
- Characterization of the novel 5-HT3 antagonists MDL 73147EF (dolasetron mesilate) and MDL 74156 in NG108-15 neuroblastoma × glioma cellsEuropean Journal of Pharmacology, 1992
- PharmacokineticsPublished by Taylor & Francis ,1982
- Mammalian Carbonyl ReductasesDrug Metabolism Reviews, 1980